|
Volumn 91, Issue 2, 2001, Pages 423-427
|
Preirradiation gemcitabine chemotherapy for newly diagnosed glioblastoma: A phase II study
|
Author keywords
Chemotherapy; Gemcitabine; Glioblastoma; Radiotherapy; Toxicity
|
Indexed keywords
GEMCITABINE;
ADULT;
AGED;
ARTICLE;
BLEEDING;
BONE MARROW TOXICITY;
CANCER CHEMOTHERAPY;
CANCER GRADING;
CANCER GROWTH;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERANCE;
FEBRILE NEUTROPENIA;
FEMALE;
GLIOBLASTOMA;
HUMAN;
MALE;
NEUROTOXICITY;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
SURVIVAL RATE;
THROMBOCYTOPENIA;
TREATMENT PLANNING;
|
EID: 0035863127
PISSN: 0008543X
EISSN: None
Source Type: Journal
DOI: 10.1002/1097-0142(20010115)91:2<423::AID-CNCR1017>3.0.CO;2-H Document Type: Article |
Times cited : (30)
|
References (16)
|